Rezidor Announces the Radisson Blu Golden Horn Hotel, Istanbul

Rezidor has announced the Radisson Blu Golden Horn Hotel, Istanbul.

2011-06-10

BRUSSELS, BELGIUM, June 10, 2011 (Press-News.org) The Rezidor Hotel Group, one of the fastest growing hotel companies worldwide, announces the Radisson Blu Golden Horn Hotel, Istanbul. The new property featuring 133 guest rooms is scheduled to open in Q1 2013. The building is owned by Dilek Holding which also owns the Radisson Blu Sisli in Istanbul.

"Our core brand Radisson Blu is the largest upper upscale brand in Istanbul - our portfolio now comprises 5 hotels with 1,000 rooms in operation and under development. Istanbul and Turkey overall are important markets for us as they offer considerable opportunities both within the business and leisure segment", said Kurt Ritter, president & CEO of Rezidor.

The group's offer in Istanbul stretches from the airport (Radisson Blu Conference & Airport Hotel), across the continental divide (Radisson Blu Istanbul Asia), into the upmarket Sisli district (Radisson Blu Sisli), along the Bosphorus (Radisson Blu Bosphorus Hotel), and finally to the banks of the Golden Horn.

The Radisson Blu Golden Horn Hotel will be located in the trendy and cosmopolitan Pera neighbourhood and will be facing the Golden Horn, the famous inlet of the Bosphorus dividing the city. Next to the property is the legendary Pera Palace Hotel, the oldest luxury hotel in Istanbul, which formerly accommodated passengers travelling on the Orient Express train.

Besides 133 contemporary guest rooms with unique views across the Golden Horn and into the heart of Istanbul, and with Radisson Blu signature services such as free high-speed Internet access, the hotel will have an all-day dining restaurant, 800m2 of meeting space, and a wellness area with an indoor swimming pool. A focal point will be the chic rooftop restaurant and bar offering spectacular views and tempting cuisine.

Istanbul is a true cultural capital. In its long and illustrious history, it has served as the capital city of the Roman Empire, the Eastern Roman (Byzantine) Empire, the Latin Empire, and the Ottoman Empire. The architectural and cultural legacies of these fallen empires remain as the city was chosen as joint European Capital of Culture for 2010.

About The Rezidor Hotel Group:
The Rezidor Hotel Group is one of the fastest growing hotel companies in the world. The group features a portfolio of more than 400 hotels in operation and under development with 86,300 rooms in over 60 countries, including a wide range of Dublin hotels, Cork hotels in city centre, hotels in Limerick, hotels in Athlone and hotels in Cavan.

Rezidor operates the brands Radisson Blu Hotels & Resorts, Park Inn by Radisson and Country Inns & Suites in Europe, Middle East and Africa, along with the goldpoints plusSM loyalty programme for frequent hotel guests. Under a worldwide licence agreement with the iconic Italian fashion house Missoni, Rezidor also operates and develops the new lifestyle brand Hotel Missoni.

Website: http://www.radissonblu.com/

ELSE PRESS RELEASES FROM THIS DATE:

Bigmouthmedia Appoints Mike Mason as Director of Product Portfolio

2011-06-10

Bigmouthmedia, global digital media company, has announced the appointment of Mike Mason as director of product portfolio. Underlining the company's commitment to high quality client service, Mike's role will see him take operational responsibility for delivering a programme of best practice and continuous improvement to services across the entire bigmouthmedia client roster. Mike will also take ownership of the day-to-day running of a broad range of services including search engine optimization, PPC, performance marketing, usability and reporting & analytics for ...

Study confirms safety, cancer-targeting ability of nutrient in broccoli, other vegetables

2011-06-10

CORVALLIS, Ore. – Sulforaphane, one of the primary phytochemicals in broccoli and other cruciferous vegetables that helps them prevent cancer, has been shown for the first time to selectively target and kill cancer cells while leaving normal prostate cells healthy and unaffected. The findings, made by scientists in the Linus Pauling Institute at Oregon State University, are another important step forward for the potential use of sulforaphone in cancer prevention and treatment. Clinical prevention trials are already under way for its use in these areas, particularly prostate ...

New animal study shows promise for development of Parkinson's disease drug

2011-06-10

Amsterdam, NL, 9 June 2011 – Few treatments for Parkinson's disease (PD) restore function for extended periods. In a new study published today in the inaugural issue issue of the Journal of Parkinson's Disease, an international group of researchers report that platelet-derived growth factor-BB (PDGF-BB) restored function in rodents and shows promise as a clinical candidate drug for treatment of PD. Parkinson's disease is the second most common neurodegenerative disorder, affecting 1𔃀% of the population over the age of 65. It is characterized by loss of brain cells ...

New method for measuring Parkinson's disease prevalence reveals sharp increase in Israel

2011-06-10

Amsterdam, NL, 9 June 2011 – In a new study published today in the inaugural issue of the Journal of Parkinson's Disease, Israeli researchers report that by tracking pharmacy purchases of anti-Parkinson drugs they could estimate the number of Parkinson's disease (PD) cases in a large population. The study identified a sharp rise in PD prevalence from 170/100,000 in 2000 to 256/100,000 in 2007 in Israel, which warrants further investigation. Surprisingly, much of the world lacks accurate figures for the percentage of the population (prevalence) with PD and the rate of ...

Chemistry with sunlight

2011-06-10

The idea is simple, says Kevin Moeller, PhD, and yet it has huge implications. All we are recommending is using photovoltaic cells (clean energy) to power electrochemical reactions (clean chemistry). Moeller is the first to admit this isn't new science. "But we hope to change the way people do this kind of chemistry by making a connection for them between two existing technologies," he says. To underscore the simplicity of the idea, Moeller and his co-authors used a $6 solar cell sold on the Internet and intended to power toy cars to run reactions described in an article ...

Confused.com Reveals 56% of Drivers Forget Where They Park

2011-06-10

Confused.com has revealed that 56% of UK drivers have at some point, forgotten where they have parked their car, and 3% have picked up the phone to ask their breakdown service to help them find it. More than 50 in 2,000 drivers in the UK admit to making that call according to a new survey by car insurance comparison site Confused.com. The Confused.com survey has revealed some of the gaffes of UK drivers, which have led them to phone for their breakdown service, like 25% of drivers have locked their keys in the car and 10% of drivers have had to call for their breakdown ...

Landmark study analyzes scientific productivity and impact of the top 100 PD investigators

2011-06-10

Amsterdam, NL, June 9, 2011 – IOS Press is pleased to announce the publication of a landmark study in which both traditional and innovative scientometric approaches have been employed to identify the top 100 Parkinson's disease (PD) investigators since 1985 and measure their scientific productivity as well as the impact of their contributions to the field. The article appears today in the inaugural issue of the Journal of Parkinson's Disease. This milestone analysis has been conducted by Aaron A. Sorensen, a noted expert in the fields of scientometrics and bibliometrics ...

Mayo Clinic-led research team tests alternative approach to treating diabetes

2011-06-10

JACKSONVILLE, Fla. — In a mouse study, scientists at Mayo Clinic Florida have demonstrated the feasibility of a promising new strategy for treating human type 2 diabetes, which affects more than 200 million people worldwide. In type 2 diabetes, the body stops responding efficiently to insulin, a hormone that controls blood sugar. To compensate for the insensitivity to insulin, many diabetes drugs work by boosting insulin levels; for example, by injecting more insulin or by increasing the amount of insulin secreted from the pancreas. The new study, published in the ...

Executive Healthcare Provider EliteHealth Selected by Holman Auto's Executive Team

2011-06-10

A leading provider of executive health and corporate health programs, concierge medical service EliteHealth has been selected by the southern division of Holman Automotive Group - one of the nation's top auto dealership and leasing companies - to provide a Wellness Program for their managerial staff. The move follows a successful implementation of EliteHealth's Executive Wellness Program in 2010, which has provided concierge medical services to 15 of Holman's southern executive management group. More and more companies are recognizing that corporate success is dependent ...

Cancer protein discovery may aid radiation therapy

2011-06-10

BOSTON--Scientists at Dana-Farber Cancer Institute have uncovered a new role for a key cancer protein, a finding that could pave the way for more-effective radiation treatment of a variety of tumors. Many cancers are driven in part by elevated levels of cyclin D1, which allow the cells to escape growth controls and proliferate abnormally. In the new research, reported in the June 9 issue of Nature, researchers discovered that cyclin D1 also helps cancer cells to quickly repair DNA damage caused by radiation treatments, making the tumors resistant to the therapy. Based ...

Menarini Group and Insilico Medicine enter a second exclusive global license agreement for an AI discovered preclinical asset targeting high unmet needs in oncology

Rezidor Announces the Radisson Blu Golden Horn Hotel, Istanbul

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: